Latest News

Charbel Moussa, MD, PhD and Fernando Pagan, MD
Study: Cancer Drug Restores Important Brain Dopamine in Parkinson’s Patients
A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.

Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease.

Huntington Disease Center at Georgetown Designated As Center of Excellence
The Huntington’s Disease Society of America (HDSA) has designated the Huntington Disease Care, Education and Research Center at Georgetown as an HDSA Center of Excellence for 2016.

Georgetown Hosts Research Summit on Concussions in Females
Georgetown Hosts Research Summit on Concussions in Females
Georgetown University Medical Center will host the first summit to explore gender differences of female brain injuries